Japan’s drug pricing panel held its final round of industry hearings on December 10 as it heads toward the FY2026…
HOME > BUSINESS
BUSINESS
- Global PIII for Xtandi Launched for Hormone Sensitive Prostate Cancer: Astellas
March 28, 2016
- Takashi Nakamura to Be Promoted to President of Qol
March 25, 2016
- Public Knowledge-Based Application Filed for Colchicine for Familial Mediterranean Fever
March 25, 2016
- MSD Going Full Out for Sakigake-Designated Pembrolizumab, Poised to Bolster Oncology Force
March 25, 2016
- Lilly Japan Logs 236 Billion Yen in 2015, Set to Further Boost Sales Force from 2,000
March 25, 2016
- Sosei Group Taps GSK Veteran Peter Bains as Next CEO
March 24, 2016
- Eisai Withdraws Japan NDA for Ultra-High Dose Mecobalamin for ALS
March 24, 2016
- Hengrui to Apply for Sakigake Designation; Develop New Drugs Alongside Generics in Japan
March 24, 2016
- Eisai to Return US Rights to Helsinn’s Antiemetic Akynzeo
March 23, 2016
- Valixa Filed for Prevention of CMV Disease in Organ Transplants: Mitsubishi Tanabe
March 23, 2016
- Romosozumab Yields Positive PIII Data in Male Osteoporosis: Amgen Astellas
March 23, 2016
- Higher Remission Rates in TNF Blocker-Naïve Patients Observed in Long-Term Vedolizumab Treatment
March 23, 2016
- Santen to Form JV with China’s Kerui for Generic Eye Drugs
March 23, 2016
- Opdivo Filed for Hodgkin’s Lymphoma in Japan
March 22, 2016
- Mochida to Codevelop Ajinomoto’s Oral Constipation Drug
March 22, 2016
- Jitsubo Aims to Launch Peptide Generic Drugs Using Its Unique Technologies
March 22, 2016
- Drug Makers Terminate Lysozyme, Pronase Sale after MHLW Panel Finds Them Ineffective
March 18, 2016
- Hisamitsu, Asahi Kasei End Sales Partnership for Neoxy Tape
March 18, 2016
- Meiji Seika Pharma, RIKEN Collaborate on Skin Regeneration Research
March 17, 2016
- Takeda, Orexigen to Wind Up Sales Collaboration for Contrave
March 17, 2016
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…